T raumatic injury is the leading cause of death among young people and the fifth leading cause of death overall in the United States (1) . The majority of these deaths occur immediately after the injury. Those who survive this initial time period are at risk for developing nosocomial infections. Bacteremia, one of many possible nosocomial infections, is associated with poor outcomes, and its prevalence, particularly due to Gram-negative organisms, is increasing (2) (3) (4) (5) . We observed that 14% of trauma victims with ventilator-associated pneumonia (VAP) had concomitant bacteremia which was associated with markedly increased length of ICU stays and a 2.5-fold increased risk of death (6) .
Immune competence requires the detection, recognition, and destruction of invading microorganisms. The ability of bacteria to access and survive in the bloodstream likely represents a profound failure of the immune response (7) . Impaired immune competence after trauma is common. However, it has not been possible to correlate postinjury immune and inflammatory alterations with subsequent infectious complications.
The "Inflammation and the Host Response to Injury" program was a multicenter collaborative research project designed to increase our understanding of the host's response to injury and the severe systemic inflammatory response that accompanies it. The data and samples collected as part of this program have improved our understanding of the overall response to traumatic injury and the development of subsequent complications. The data have also allowed us to address two objectives regarding bacteremia. First, we sought to confirm whether bacteremia was associated with a poor prognosis, as we previously observed in trauma patients with VAP. Second, we tested whether early gene expression patterns in patients with bacteremia differed from other severely injured patients.
MATERIALS AND METHODS

Patient Recruitment and Enrollment
We analyzed data gathered from the Inflammation and the Host Response to Injury research program. The organization details, overall scope, and patient recruitment procedures of the program have been previously described (8) . Briefly, 1,819 subjects were enrolled from seven U.S. level I trauma centers from 2003 to 2009. Subjects were enrolled if they had a blunt injury mechanism, had prehospital or emergency department (ED) hypotension (systolic blood pressure [SBP] < 90 mm Hg) or an elevated base deficit (> 6 mEq/L), required blood transfusion within the first 12 hours after injury, and had an Abbreviated Injury Scale (AIS) score of more than 2 for any body region other than the brain.
The study subjects were treated in accordance with the standard operating procedures (SOPs) adopted by all seven of the participating centers to minimize variations across centers. The SOPs address resuscitation strategies, mechanical ventilation, sedation and analgesia use, diagnosis and treatment of VAP, nutritional support, and other specific aspects of care. The SOPs have been previously described (9) (10) (11) (12) (13) (14) (15) (16) .
Subjects were excluded from our analysis if they had an ICU stay of less than 3 days (either due to death or discharge) using the rationale that bacterial infections in those subjects are less likely due to sequelae of nosocomial pathogen exposure in the ICU. The demographic information that was collected included age, gender, body mass index (BMI), measurements of severity of injury and illness (Injury Severity Score [ISS], Acute Physiology and Chronic Health Evaluation [APACHE] II, and AIS scores), and details of each subject's hospital course including the development of Gram-negative bacteremia (GNB). This is a secondary analysis of de-identified data and is therefore classified as exempt by the University of Washington Human Subjects Division.
Statistical Analysis
Clinical data were evaluated using Stata 12 statistical software (StataCorp LP, College Station, TX). Continuous data, with the exception of the gene expression values, are presented as medians and range and were compared using Mann-Whitney U tests. Categorical data are presented as values and percentages and were compared using chi-square test or Fisher exact test. Actual p values for all comparisons are presented. Both univariate and step-wise logistic regressions were performed to determine the risk of death associated with bacteremia. Variables were included in the final regression model if their individual p value for association with death was less than or equal to 0.1. Graphs were made using Prism (GraphPad Software, La Jolla, CA).
Propensity Score Matching
To eliminate some of the inherent heterogeneity in the gene expression values of our cohort, we matched each subject in whom GNB developed to two to three subjects in whom GNB did not develop (non-GNB) using propensity scores for the development of GNB (17) . The propensity score for the development of GNB was predicted from a multivariate logistic regression model that included the following variables: age; gender; BMI; ISS; APACHE II scores; AIS scores for the head, face, neck, chest, abdomen, spine, and extremities; lowest SBP and Glasgow Coma Scale from their ED stay; the ED base deficit; maximum blood glucose level in the first 24 hours; the number of units of packed RBCs (PRBCs); and volume of crystalloid received in the first 12 hours after injury. Using nearest neighbor matching, each subject with GNB was matched to two to three subjects without GNB based on their proximity in the database which also represented sequential enrollment in the study. Matching was done using ± 0.05 of the propensity score.
Gene Expression Data
The method for the collection of samples and generation of transcriptional profiles has been previously reported (8, 18) . Patient samples were applied to Affymetrix U133 plus 2.0 Gene Chip platforms (Affymetrix, Santa Clara, CA), and the intensity signal was uploaded to the Trauma Research Database as CEL files. Only the CEL files of subjects with multiple time points and RNA quality more than or equal to 2 were included in the genomic analysis. The CEL files were perfect-matched normalized in dChip (Boston, MA) prior to analysis (19) . The signals were then converted and exported as expression values. Settings for the dChip analysis can be found in the supplemental material (Supplemental Digital Content 1, http://links.lww.com/CCM/A861).
Gene Expression Analysis
The normalized expression values were adjusted for batch effect using the open access R program (Boston, MA), ComBat.R for samples from time points of 12 and 96 hours postinjury to minimize nonbiological variation (20) . ComBat.R processes and settings are detailed in Supplemental material (Supplemental Digital Content 1, http://links.lww.com/CCM/A861). The normalized and batch-corrected expression values for the subjects with GNB and matched subjects without GNB were then imported into GenePattern (Broad Institute, MIT, Cambridge, MA) (21) . Using ComparativeMarkerSelection (22) (23) (24) (25) , the values were analyzed to determine the probe sets that were differentially expressed between the subjects with GNB and those without at each time point (12 hr and 96 hr after injury) using a two-sided t test. The output of the analysis includes a ranking of the probe sets based on the value of the t test and adjusts for multiple hypothesis testing using false discovery rate. Details of the settings used in GenePattern can be found in Supplemental material (Supplemental Digital Content 1, http://links.lww.com/CCM/A861). Then, using the ExtractComparativeMarkerSelection feature in GenePattern, we exported the top 200 ranked probe sets. Using a cutoff of more than or equal to 1.5-fold differential expression, the probe sets representing genes that are known to be involved in either the innate or adaptive immune system were identified and compared with the expression of the same probe sets at the alternate time point from the normalized and batch-corrected data. Gene expression values are presented as mean ± sd.
RESULTS
Characteristics of the Entire Cohort
Data for 1,819 subjects were available and extracted from the database (data abstraction in June 2011). Of those subjects, 224 had an ICU stay of less than 3 days and were excluded from our analysis. The remaining 1,595 subjects were included in our initial analysis.
Patient and injury characteristics and outcomes are included in Table 1 and summarized here. One third of subjects had a severe traumatic brain injury, two thirds had severe chest injury, and nearly half had severe abdominal injury. GNB developed in 8% of subjects and Gram-positive bacteremia developed in 8% of subjects. They had long ICU and hospital length of stays and in-hospital mortality of 11%.
Gram-Negative, But Not Gram-Positive, Bacteremia Is Associated With Increased Mortality
GNB developed in 127 subjects and Gram-positive bacteremia occurred in 131. A number of factors were associated with mortality, and these are shown in Table 2 .
GNB was found to be an independent risk factor for death (odds ratio [OR], 1.86; 95% CI, 1.13-3.08; p = 0.015). However, Gram-positive bacteremia was not. Other factors that were associated with death included age, APACHE II score, and units of PRBCs in first 12 hours. The results of the logistic regression analysis are shown in Table 3 .
We then focused on determining whether there were differences in early gene expression in these subjects that could explain a predisposition to subsequent GNB.
Selection of Microarrays by Propensity Score Matching
A total of 121 subjects had total leukocyte microarray data that met sample quality specifications at within 12 and 96 hours after injury. Bacteremic subjects differed markedly from the nonbacteremic subjects as summarized in Table 4 . Both amount of blood transfusion received and ISS have been associated with increased risk of bacteremia following trauma (26) . Additionally, transfusion of PRBCs alters gene expression, typically seen as an up-regulation of inflammatory genes (27) . To minimize the impact of potential confounding factors, we used propensity score matching to select patients, and therefore microarrays, that were as closely matched as possible on factors that contribute to the risk of GNB and that might also directly affect gene expression. Propensity scores allowed us to match the 10 subjects with GNB to 26 subjects without ( Table 5) .
Genome-Wide Expression Analysis
A heatmap of the top 100 differentially expressed at 12 hours probe sets is shown in Figure 1A . Of the top ranked probe sets with more than or equal to 1.5-fold differential expression (increased or decreased), none represented genes in the innate or adaptive immune system.
A heatmap illustrating the top 100 differentially expressed probe sets is shown in Figure 1B . Of the top ranked probes with more than or equal to 1.5-fold differential expression, 20 represented 15 genes in the innate or adaptive immune system. The expression data for all 20 probe sets at both 96 and 12 hours after injury can be found in Supplemental 
Analysis of Individual Immune-Related Genes
At the 96-hour time point, 10 inflammatory, two counter-regulatory, and three adaptive immune system genes were differentially expressed. These include interleukin-1β (IL1B) ( Fig. 2A) and interleukin-2 receptor β (IL2RB) (Fig. 2B) . IL1B expression was similar between groups at 12 hours, but at 96 hours, the subjects in whom GNB developed had a progressive decrease in gene expression, whereas the expression of IL1B in subjects in whom GNB did not develop remained relatively constant. Expression of IL2RB followed a similar pattern. Granzyme A, chemokine (C-X3-C motif) receptor 1, chemokine (C-C motif) ligand 3-like 3 and 1, T-cell receptor α constant, killer cell lectin-like receptor subfamily B, member 1, T-cell activation RhoGTPase activating protein, and CD86 molecule expressions were also decreased at 96 hours after injury in the subjects in whom GNB developed.
Counter-regulatory interleukin-1 receptor type II (IL1R2) (Fig. 3A) and CD 163 molecule (CD163) (Fig. 3B) were increased at 96 hours after injury in the subjects in whom GNB developed compared with those in whom it did not develop. Specifically, IL1R2 expression was similar between the two groups at 12 hours. At 96 hours, expression remained relatively higher in those destined to develop GNB. Conversely, CD163 expression was similar between the two groups at 12 hours but decreased to a far greater degree by 96 hours in patients without bacteremia.
Human leukocyte antigen (HLA) genes showed decreased expression at 96 hours after injury in the subjects in whom GNB developed (Fig. 4) . Concentrating on the two genes highlighted in the figure, for both HLA-DRA and HLA-DMB, expression was similar between the two groups at the 12-hour time point, and at 96 hours, the expression in the subjects in whom GNB developed persisted, whereas the expression in the subjects in whom GNB did not develop showed a progressive increase.
DISCUSSION
Our analysis of genome-wide gene expression demonstrates important differences between patients who subsequently developed GNB and those who did not. Up until 12 hours after Total crystalloid in first 12 hr (L) 11 (7-15) 9.6 (7-13) 0.003
Gram-negative bacteremia 27 (15) 100 (7) < 0.001
Gram-positive bacteremia 13 (7) 118 (8) injury, differences were few and unremarkable. However, by 96 hours, the differences were marked and suggest immune supression. Genes that were down-regulated at 96 hours in the subjects who developed GNB represented genes of both the innate and adaptive immune system. In contrast, counter-regulatory genes of the innate immune system were up-regulated in the subjects destined to develop GNB consistent with an overall picture of suppression of both the innate and adaptive immune system genes at 96 but not before 12 hours. The Inflammation and the Host Response to Injury collaborative recently defined the overall response to traumatic injury and described the phenomenon as a "genomic storm" (28) . In the entire study cohort, the duration of altered gene expression correlated with a prolonged and "complicated" recovery, but there were no qualitative differences in the gene expression patterns (28) . We, however, do observe differences in inflammatory and immune gene expression in the subgroup of subjects who developed GNB. By matching these bacteremic subjects to similarly severely injured control subjects, we have observed differences in both innate and adaptive immune gene expression that could lead to failure of the host to prevent Gram-negative bacteria from accessing the bloodstream. Four of the genes identified at 96 hours are important to innate immune responses. First is IL1B (2q14), which encodes interleukin (IL)-1β, which is central to the innate immune response (29) . We observed decreased expression of IL1B in the subjects who went on to develop GNB. This is consistent with a study in which investigators observed lower perioperative IL1B expression in patients who subsequently developed postoperative sepsis (30) . Second, IL2RB (22q13.1) encodes the β subunit of the IL-2 receptor. It is expressed by lymphocytes and binding with IL-2 leads to T-cell proliferation (31) . We observed lower expression of this gene in subjects in whom GNB developed, consistent with relative immune suppression. Third is IL1R2 (2q12), which encodes the IL-1 receptor type II (IL-1 type II receptor) and functions as a decoy receptor for IL-1β. IL-1 type II receptor prevents processing of the propeptide and blocks the interaction of the mature form of IL-1β with its functional receptor (32) . We observed a relative increase in IL1R2 expression which likely contributes to suppressed innate immunity in the bacteremic patients. Finally, CD163 (12p13.3) is expressed by monocytes and macrophages. Binding of such complexes to cells with CD163 binds to hemoglobin/haptoglobin complexes and increases secretion of IL-10, a known anti-inflammatory cytokine (33) . Lower IL1B and IL2RB gene expression and higher IL1R2 and CD163 suggest an overall suppression of innate immunity leading to GNB.
We observed marked decreased expression of all five of the probe sets for HLA genes (chromosome 6) and the CD86 gene in the subjects who developed GNB. Others have observed decreased expression of HLA antigens on monocytes after severe trauma (34, 35) . Decreased HLA expression has also been associated with higher infection rates in patients undergoing major operations, and the degree of decreased expression has been associated with increase in mortality from sepsis (36, 37) . Our observations and these other reports are consistent with the notion that adaptive immune suppression follows severe traumatic injury and contributes to nosocomial infections and perhaps death.
There are doubtless many factors that contribute to alterations in early gene expression and may therefore ultimately lead to GNB. As shown in Table 4 , there were many differences in measures of injury severity, shock severity, and treatments received (crystalloid and blood transfusions) between patients with and without GNB. These risk factors for bacteremia and other infectious outcomes have been reported by others, and each clearly could contribute to the differences in gene expression that we observed at 96 hours after injury. Differences were not yet large or consistent enough to be manifested by the first sampling time point. Despite the effectiveness of propensity matching in reducing the differences between the bacteremic and nonbacteremic subjects, there were still some differences as could be seen in Table 5 . Bacteremic patients were more likely male and received more blood in the first 12 hours. Both of these factors may have, in part, contributed to the differences in gene expression and therefore to the development of GNB. Our data can only hint at the potential mechanisms linking the clinical risk factors with gene expression and eventual outcomes.
Our study has important limitations. First, the gene expression profiles were measured from total leukocyte samples, the majority of which are neutrophils, which potentially masks differences in gene expression from minority cell types, such as monocytes. However, the reciprocal increases in CD163 and Figure 2. Proinflammatory innate immune system genes interleukin-1β (IL1B) and interleukin-2 receptor β (IL2RB) are similarly expressed in both subjects in whom Gram-negative bacteremia (GNB) developed and those in whom GNB did not develop (non-GNB) within 12 hr after injury. At 96 hr after injury, the gene expression in the non-GNB subjects persisted, whereas that in the GNB subjects progressively decreased so that both genes showed decreased expression in GNB subjects at 96 hr. Gene expression is presented as units ± sd. Figure 3 . Counter-regulatory innate immune system gene expression is increased in subjects in whom Gram-negative bacteremia developed (GNB) compared with those in whom GNB did not develop (non-GNB). Within 12 hr after injury, expression interleukin-1 receptor type II (IL1R2) is similar in both groups, but by 96 hr, expression in the GNB subjects has persisted, whereas that in non-GNB subjects has decreased. Expression of CD163 molecule (CD163) is also similar between the two groups within 12 hr after injury, and at 96 hr, expression has decreased in both groups but to a greater degree in the non-GNB subjects. Gene expression is presented as units ± sd.
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June 2014 • Volume 42 • Number 6 IL1R2, both primarily expressed by monocytes, indicate that we were not observing simply a relative reduction in monocyte RNA in subjects who subsequently developed GNB. Second, our analysis was limited by having relatively few bacteremic subjects with available gene expression data. Having more cases may have given us more power to identify other differences in gene expression, which may have resulted in an overall different interpretation of global changes in gene expression. As it is, our limited number of subjects likely resulted in fewer genes meeting the genome-wide threshold for significance. Third, our data and conclusions rely solely on the results of the microarray analyses without any confirmation by individual gene real-time polymerase chain reaction (rtPCR) or other measurements of protein products. However, we have taken a number of steps to ensure that our gene expression results are robust and that they are derived from quality RNA samples that were managed and analyzed correctly. Nevertheless, as we progress further along this path, we will look at individual gene expression with rtPCR. Although we have retrospectively reviewed the clinical and gene expression data, the datasets are robust, complete, and include most of the data needed to address our research question. Importantly, having genome-wide expression data allowed us to assess the global inflammatory state in an unbiased manner.
We believe our observations have important implications for understanding and possibly preventing posttraumatic GNB. For example, recent focus has been on reducing the prevalence of bacteremia and other catheter-related infections by using "bundles" based on guidelines that were established to ensure consistency of technique (38, 39) . Doubtless, these interventions are important and have reduced infectious complications in hospitalized patients. However, despite these system-wide approaches, recent reports suggest an increasing prevalence of bacteremia, particularly with Gram-negative organisms (3) (4) (5) . These reports indicate that although bacteremia can be reduced by these interventions, many occur despite optimized care and likely reflect factors specific to the individual patient, such as alterations in their immune response, as demonstrated here. We believe that without interventions aimed at injury-induced alterations in both innate and adaptive immunity, system-wide interventions will not eliminate GNB. Targeting the use of immunostimulants, such as interferon-γ, in patients with decreased immune gene expression could potentially lead to improved outcomes. Figure 4 . Proinflammatory adaptive immune system gene expression is decreased in subjects in whom Gram-negative bacteremia developed (GNB) compared with those in whom GNB did not develop (non-GNB). Within 12 hr after injury, expression of major histocompatibility complex, class II, DR α (HLA-DRA) and major histocompatibility complex class II, DM β (HLA-DMB) are similar between the two groups, but at 96 hr, expression in the non-GNB subjects had increased, whereas the expression in the GNB subjects had persisted. Gene expression is presented as units ± sd.
